{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:57:20Z","timestamp":1723615040509},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,25]]},"DOI":"10.7759\/cureus.17448","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T03:20:07Z","timestamp":1629948007000},"source":"Crossref","is-referenced-by-count":3,"title":["Gastrointestinal Stromal Tumor With Chondrosarcomatous Dedifferentiation Following Imatinib Therapy"],"prefix":"10.7759","author":[{"given":"Nektarios","family":"Koufopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andriani","family":"Zacharatou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Athanasiadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Periklis","family":"Tomos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Ekonomopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Liakakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis G","family":"Panayiotides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2018.12.005","article-title":"Dedifferentiated gastrointestinal stromal tumor: recent advances","volume":"39","author":"Karakas C","year":"2019","unstructured":"Karakas C, Christensen P, Baek D, Jung M, Ro JY. Dedifferentiated gastrointestinal stromal tumor: recent advances. Ann Diagn Pathol. 2019, 39:118-24. 10.1016\/j.anndiagpath.2018.12.005","journal-title":"Ann Diagn Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20970","article-title":"Gastrointestinal stromal tumors and leiomyosarcomas","volume":"97","author":"Katz SC","year":"2008","unstructured":"Katz SC, DeMatteo RP. Gastrointestinal stromal tumors and leiomyosarcomas. J Surg Oncol. 2008, 97:350-9. 10.1002\/jso.20970","journal-title":"J Surg Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/0300060518791677","article-title":"Primary prostatic extragastrointestinal stromal tumor: a case report and literature review","volume":"46","author":"You YH","year":"2018","unstructured":"You YH, Zhang Y. Primary prostatic extragastrointestinal stromal tumor: a case report and literature review. J Int Med Res. 2018, 46:4343-9. 10.1177\/0300060518791677","journal-title":"J Int Med Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.7461","article-title":"Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor","volume":"26","author":"Heinrich MC","year":"2008","unstructured":"Heinrich MC, Maki RG, Corless CL, et al.. Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. J Clin Oncol. 2008, 26:5352-9. 10.1200\/JCO.2007.15.7461","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2005.02179.x","article-title":"Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall","volume":"47","author":"Pauwels P","year":"2005","unstructured":"Pauwels P, Debiec-Rychter M, Stul M, De Wever I, Van Oosterom AT, Sciot R. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall. Histopathology. 2005, 47:41-7. 10.1111\/j.1365-2559.2005.02179.x","journal-title":"Histopathology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/317493","article-title":"Rhabdomyosarcomatous transformation of a gastrointestinal stromal tumor following treatment with iImatinib","volume":"2015","author":"Jiang X","year":"2015","unstructured":"Jiang X, Anderson HB, Guy CD, Mosca PJ, Riedel RF, Cardona DM. Rhabdomyosarcomatous transformation of a gastrointestinal stromal tumor following treatment with iImatinib. Case Rep Oncol Med. 2015, 2015:317493. 10.1155\/2015\/317493","journal-title":"Case Rep Oncol Med"},{"key":"ref7","article-title":"Recurrent retroperitoneal extra-GIST with rhabdomyosarcomatous and chondrosarcomatous differentiations: a rare case and literature review","volume":"8","author":"Zhu P","year":"2015","unstructured":"Zhu P, Fei Y, Wang Y, Ao Q, Wang G. Recurrent retroperitoneal extra-GIST with rhabdomyosarcomatous and chondrosarcomatous differentiations: a rare case and literature review. Int J Clin Exp Pathol. 2015, 8:9655-61.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31826c1761","article-title":"Dedifferentiation in gastrointestinal stromal tumor to an anaplastic KIT-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy","volume":"37","author":"Antonescu CR","year":"2013","unstructured":"Antonescu CR, Romeo S, Zhang L, et al.. Dedifferentiation in gastrointestinal stromal tumor to an anaplastic KIT-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy. Am J Surg Pathol. 2013, 37:385-92. 10.1097\/PAS.0b013e31826c1761","journal-title":"Am J Surg Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31817ec2e6","article-title":"Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression","volume":"33","author":"Liegl B","year":"2009","unstructured":"Liegl B, Hornick JL, Antonescu CR, Corless CL, Fletcher CD. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression. Am J Surg Pathol. 2009, 33:218-26. 10.1097\/PAS.0b013e31817ec2e6","journal-title":"Am J Surg Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-010-1034-1","article-title":"An unusual and potentially misleading phenotypic change in a primary gastrointestinal stromal tumour (GIST) under imatinib mesylate therapy","volume":"458","author":"Vassos N","year":"2011","unstructured":"Vassos N, Agaimy A, Schlabrakowski A, Hohenberger W, Schneider-Stock R, Croner RS. An unusual and potentially misleading phenotypic change in a primary gastrointestinal stromal tumour (GIST) under imatinib mesylate therapy. Virchows Arch. 2011, 458:363-9. 10.1007\/s00428-010-1034-1","journal-title":"Virchows Arch"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.7989","article-title":"High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors","volume":"31","author":"Martz J","year":"2013","unstructured":"Martz J, Jain S, Vahdat LT, Qin L, Mosquera JM, Antonescu CR, Popa EC. High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors. J Clin Oncol. 2013, 31:e181-5. 10.1200\/JCO.2012.42.7989","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12095","article-title":"Gastrointestinal stromal tumor with dedifferentiation to undifferentiated pleomorphic sarcoma","volume":"63","author":"Jung JH","year":"2013","unstructured":"Jung JH, Im S, Choi HJ, Lee YS, Jung ES. Gastrointestinal stromal tumor with dedifferentiation to undifferentiated pleomorphic sarcoma. Pathol Int. 2013, 63:479-82. 10.1111\/pin.12095","journal-title":"Pathol Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2013.12.008","article-title":"Dedifferentiated gastrointestinal stromal tumor arising de novo from the small intestine","volume":"210","author":"Choi JJ","year":"2014","unstructured":"Choi JJ, Sinada-Bottros L, Maker AV, Weisenberg E. Dedifferentiated gastrointestinal stromal tumor arising de novo from the small intestine. Pathol Res Pract. 2014, 210:264-6. 10.1016\/j.prp.2013.12.008","journal-title":"Pathol Res Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009031","article-title":"Gastrointestinal stromal tumor of unusual phenotype after imatinib treatment: a case report and diagnostic utility of ETV1 mRNA in situ hybridization","volume":"96","author":"Jung M","year":"2017","unstructured":"Jung M, Park SH, Jeon YK, Won JK, Yang HK, Kim WH. Gastrointestinal stromal tumor of unusual phenotype after imatinib treatment: a case report and diagnostic utility of ETV1 mRNA in situ hybridization. Medicine (Baltimore). 2017, 96:e9031. 10.1097\/MD.0000000000009031","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6085-3","article-title":"Case report of rhabdomyosarcomatous transformation of a primary gastrointestinal stromal tumor (GIST)","volume":"19","author":"Li L","year":"2019","unstructured":"Li L, Khalili M, Johannes G, et al.. Case report of rhabdomyosarcomatous transformation of a primary gastrointestinal stromal tumor (GIST). BMC Cancer. 2019, 19:913. 10.1186\/s12885-019-6085-3","journal-title":"BMC Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-241442","article-title":"Rare case of a duodenal de novo dedifferentiated gastrointestinal stromal tumour","volume":"14","author":"Shah PA","year":"2021","unstructured":"Shah PA, Babu R, Uthaiah SB, Patil S. Rare case of a duodenal de novo dedifferentiated gastrointestinal stromal tumour. BMJ Case Rep. 2021, 14:e241442. 10.1136\/bcr-2020-241442","journal-title":"BMJ Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.123545","article-title":"Diagnosis of gastrointestinal stromal tumors: a consensus approach","volume":"33","author":"Fletcher CD","year":"2002","unstructured":"Fletcher CD, Berman JJ, Corless C, et al.. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002, 33:459-65. 10.1053\/hupa.2002.123545","journal-title":"Hum Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota S","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y, et al.. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998, 279:577-80. 10.1126\/science.279.5350.577","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.05.140","article-title":"Biology of gastrointestinal stromal tumors","volume":"22","author":"Corless CL","year":"2004","unstructured":"Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol. 2004, 22:3813-25. 10.1200\/JCO.2004.05.140","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/srep05907","article-title":"Frequent KIT mutations in human gastrointestinal stromal tumors","volume":"4","author":"Xu Z","year":"2014","unstructured":"Xu Z, Huo X, Tang C, et al.. Frequent KIT mutations in human gastrointestinal stromal tumors. Sci Rep. 2014, 4:5907. 10.1038\/srep05907","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2015.2613","article-title":"Analysis of mutation of the c-Kit gene and PDGFRA in gastrointestinal stromal tumors","volume":"10","author":"Xu CW","year":"2015","unstructured":"Xu CW, Lin S, Wang WL, et al.. Analysis of mutation of the c-Kit gene and PDGFRA in gastrointestinal stromal tumors. Exp Ther Med. 2015, 10:1045-51. 10.3892\/etm.2015.2613","journal-title":"Exp Ther Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2230","article-title":"KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors","volume":"18","author":"Miranda C","year":"2012","unstructured":"Miranda C, Nucifora M, Molinari F, et al.. KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors. Clin Cancer Res. 2012, 18:1769-76. 10.1158\/1078-0432.CCR-11-2230","journal-title":"Clin Cancer Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2010.03.001","article-title":"Succinate dehydrogenase - Assembly, regulation and role in human disease","volume":"10","author":"Rutter J","year":"2010","unstructured":"Rutter J, Winge DR, Schiffman JD. Succinate dehydrogenase - Assembly, regulation and role in human disease. Mitochondrion. 2010, 10:393-401. 10.1016\/j.mito.2010.03.001","journal-title":"Mitochondrion"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPPCKGA2QGBJ1R","article-title":"BRAF mutation status in gastrointestinal stromal tumors","volume":"133","author":"Hostein I","year":"2010","unstructured":"Hostein I, Faur N, Primois C, et al.. BRAF mutation status in gastrointestinal stromal tumors. Am J Clin Pathol. 2010, 133:141-8. 10.1309\/AJCPPCKGA2QGBJ1R","journal-title":"Am J Clin Pathol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2009.064550","article-title":"V600E BRAF mutations are alternative early molecular events in a subset of KIT\/PDGFRA wild-type gastrointestinal stromal tumours","volume":"62","author":"Agaimy A","year":"2009","unstructured":"Agaimy A, Terracciano LM, Dirnhofer S, Tornillo L, Foerster A, Hartmann A, Bihl MP. V600E BRAF mutations are alternative early molecular events in a subset of KIT\/PDGFRA wild-type gastrointestinal stromal tumours. J Clin Pathol. 2009, 62:613-6. 10.1136\/jcp.2009.064550","journal-title":"J Clin Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/68237-gastrointestinal-stromal-tumor-with-chondrosarcomatous-dedifferentiation-following-imatinib-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:14Z","timestamp":1707507014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/68237-gastrointestinal-stromal-tumor-with-chondrosarcomatous-dedifferentiation-following-imatinib-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.17448","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,25]]}}}